Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
$17.49 +0.67 (3.98%)
As of 01/27/2023 15:59:53 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.